Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Specifically, 62.9% of participants reported using at least one AC medication according to the CRIDECO Anticholinergic Load Scale (CALS), and 48.2% according to the Anticholinergic Cognitive Burden/ACB Scale
Your body is adapting to a new metabolic environment
Statistical methods CV risk prediction model As described previously, an identical 3-point composite MACE endpoint was the primary outcome for the LEADER, SUSTAIN 6 and PIONEER 6 CVOTs, and was defined as time to first occurrence of death from CV disease (CVD, including undetermined causes), non-fatal MI or non-fatal stroke [13, 26, 31]
Understanding these differences helps patients and clinicians select the most appropriate formulation based on treatment goals, lifestyle preferences, and individual medical needs
US$ 25.91
US$ 26.85
US$ 24.30
US$ 29.48
US$ 26.67
US$ 22.44
US$ 21.23
US$ 26.47
US$ 26.19
US$ 28.84
US$ 27.30
US$ 23.49
US$ 20.18
US$ 26.14
US$ 20.59
